| Cancer Information Highlights |
| From the National Cancer Institute |
| Updating you about cancer causes, prevention, screening, treatment, coping, and more |
| |
| New from NCI |
| Healthy Lifestyle May Help Former Smokers Live Longer |
 |
|
A new NCI study finds that former smokers who stick to a healthy lifestyle have a lower risk of dying from all causes, including cancer and heart and lung disease, than those who don’t have healthy habits. |
Common Chemotherapy Drugs Seem to Increase Hearing Loss
Read about new research showing that more than half of people treated with chemotherapy for the four most common types of cancer had hearing loss and tinnitus after treatment. |
| Vulnerability in Brain Tumors May Open Door to New Treatments |
 |
|
Two new studies have uncovered a vulnerability in different forms of brain tumors that may make the cancers sensitive to the same treatments. The brain tumors are gliomas, which are among the most lethal cancers. |
| Multi-Cancer Detection: Advancing Cancer Screening to Save Lives |
 |
|
Multi-cancer detection (MCD) tests that can find precancer or cancer before it causes symptoms could greatly change cancer screening. This section of the NCI Annual Plan & Budget Proposal for Fiscal Year 2024 describes how NCI investments in MCD and other screening tests will help answer important questions to end cancer as we know it today. |
| Transforming Childhood Cancer |
 |
|
The Children’s Oncology Group (COG) is an NCI-funded network of researchers and hospitals. COG Chair Dr. Doug Hawkins discusses how it functions and how it’s working to improve treatment and quality of life for children with cancer. |
Immunotherapy Drug Shows Promise for Some People with Multiple Myeloma
A new clinical trial suggests that teclistamab (Tecvayli) may help people with advanced multiple myeloma who have already had several rounds of treatment. Learn more about multiple myeloma and this new drug.
|
| FDA Approvals |
Selpercatinib
We’ve updated our selpercatinib (Retevmo) drug summary with a recent Food and Drug Administration approval. This drug is now approved to treat adults with certain solid tumors that are caused by an abnormal RET gene and have spread, have gotten worse during or after other treatment, or can’t be treated with other therapies. |
|
| |
| Also of Interest |
The Genetics of Cancer
Cancer is a genetic disease caused by changes in genes that control the way cells grow and divide. Learn more about the role genetics play in cancer. |
Advances in Breast Cancer Research
NCI-funded researchers are working to advance our understanding of how to prevent, find, and treat breast cancer. Learn more about the latest in research for breast cancer, including new advances that may soon translate into improved care, NCI-supported programs that are fueling progress, and research findings from recent studies. |
Contact Us for Help
Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email. |
|
|
|
|
|
